For accurate CJC 1295 DAC reconstitution and CJC 1295 No DAC preparation, laboratory protocols require adding bacteriostatic water to lyophilized peptide vials under sterile conditions. PX1 Research provides high-purity research peptides backed by lot-specific third-party COAs, featuring RP-HPLC and mass spectrometry verification along with endotoxin testing. Manufactured in the USA, PX1 ships all orders same-day Monday through Friday from California and Arizona hubs.
For accurate CJC 1295 DAC reconstitution and CJC 1295 No DAC preparation, laboratory protocols require adding bacteriostatic water to lyophilized peptide vials under sterile conditions. PX1 Research provides high-purity research peptides backed by lot-specific third-party COAs, featuring RP-HPLC and mass spectrometry verification along with endotoxin testing. Manufactured in the USA, PX1 ships all orders same-day Monday through Friday from California and Arizona hubs.
Reconstituting synthetic GHRH analogs such as CJC-1295 (with DAC) and CJC-1295 (without DAC / Modified GRF 1-29) requires precise volume calculations, sterile lab conditions, and proper diluent selection to preserve molecular integrity. Standard laboratory protocols employ 0.9% benzyl alcohol preserved bacteriostatic water to prevent bacterial growth during multi-dose container sampling.
Lyophilized CJC-1295 matrix cakes dissolve rapidly when diluent is directed gently against the glass vial wall. Direct high-pressure stream impact should be avoided to prevent mechanical shearing of the peptide chain. Once dissolved, the working solution must be maintained at 2°C to 8°C (36°F to 46°F) to minimize hydrolytic degradation over extended experimental timelines.
Researchers seeking reproducible assay outcomes should source verified reference material directly from the full PX1 research peptide catalog, ensuring batch-to-batch consistency across all in vitro and preclinical trials.
CJC-1295 is a synthetic 29-amino-acid analog of naturally occurring Growth Hormone-Releasing Hormone (GHRH). In preclinical models, GHRH analogs selectively bind to pituitary GHRH receptors, stimulating pulsatile production and secretion of growth hormone (GH) and downstream insulin-like growth factor 1 (IGF-1). Researchers frequently study GHRH stimulation to evaluate mechanisms of cellular proliferation, protein synthesis, and tissue repair research.
The primary structural distinction lies in the inclusion of the Drug Affinity Complex (DAC). CJC-1295 with DAC contains a maleimidopropionic acid linker that covalently binds to circulating albumin in vivo. This extends the biological half-life from approximately 30 minutes to over 6–8 days. Conversely, cjc 1295 no dac—often designated as Modified GRF 1-29—lacks this lysine-linker complex, resulting in a short half-life ideal for studying sharp, localized GH spikes.
Researchers conducting physiological pulse modeling or acute receptor activation assays generally select non-DAC variants. You can access analytical data for these variants through the PX1 scientific research database.
Executing a clean cjc 1295 dac reconstitution requires an organized bench setup inside a laminar flow hood or cleaned biological safety cabinet. Prior to beginning, gather 0.9% bacteriostatic water, sterile reconstituting syringes, 70% isopropyl alcohol wipes, and your lyophilized CJC-1295 DAC vial.
Sanitize the rubber septum of both the bacteriostatic water diluent vial and the lyophilized peptide vial with alcohol swabs. Allow the alcohol to air-dry completely to prevent chemical cross-contamination. Draw the calculated volume of diluent (typically 1.0 mL to 2.0 mL per 2 mg or 5 mg vial) into the reconstituting syringe.
Insert the needle through the center of the peptide vial stopper at a 45-degree angle. Angle the needle so the diluent flows smoothly down the interior glass surface. Allow the liquid to draw in under residual vacuum pressure if present, controlling the plunger speed. Gently swirl the vial in circular motions until the cake is fully solubilized. Never shake the vial, as vigorous agitation can induce protein denaturation.
When performing cjc no dac reconstitution, maintaining high concentration accuracy is crucial for micropipetting precision in working assays. The mathematical formula for determining solution concentration is: Concentration (mg/mL) = Total Peptide Mass (mg) / Diluent Volume (mL).
For example, when adding 2.0 mL of bacteriostatic water to a standard 5 mg vial of CJC-1295 No DAC, the resulting concentration is 2.5 mg/mL (or 2,500 mcg/mL). Adding 1.0 mL to a 2 mg vial yields a 2.0 mg/mL (2,000 mcg/mL) concentration. Selecting a standard diluent volume simplifies accurate volumetric measurement during subsequent laboratory dilutions.
To obtain consistent mass metrics for your studies, researchers can order 5 mg vials of CJC-1295 No DAC manufactured to precise analytical tolerances.
In vitro and animal models show distinct kinetics between DAC-bound and non-bound GHRH constructs. Understanding these operational differences ensures appropriate experimental design:
1. Bioavailability & Half-Life: CJC-1295 DAC maintains extended plasma persistence via albumin binding, producing sustained basal GH baseline elevation over days. CJC-1295 No DAC exhibits rapid clearance within 30 minutes, mimicking natural physiological GHRH pulses.
2. Receptor Desensitization Profile: Prolonged, continuous GHRH receptor occupancy by long-acting DAC complexes can alter down-stream receptor responsiveness. Short-acting non-DAC formulations allow pituitary somatotropes to recover between pulses.
3. Synergistic Potential: Non-DAC variants are frequently combined in secretagogue research alongside selective GHRPs, such as when evaluating Ipamorelin 5 mg research vials to measure additive GH release without baseline disruption.
Lyophilized CJC-1295 powder should be stored in a commercial freezer at -20°C for long-term storage (up to 24 months). Store away from light moisture exposure. Upon receipt, allow freeze-dried vials to equilibrate to room temperature prior to reconstitution to minimize moisture condensation inside the vial.
Post-reconstitution liquid solutions are significantly more fragile. Store reconstituted CJC-1295 vials under refrigeration at 2°C to 8°C. Do not repeatedly freeze and thaw reconstituted solutions; thermal cycling degrades the tertiary peptide structure and leads to aggregation.
If aliquoting into smaller secondary laboratory vessels is necessary, use sterile polypropylene micro-centrifuge tubes to reduce peptide surface adsorption.
Ensuring experimental repeatability requires sourcing peptides that strictly meet analytical benchmarks. When auditing vendors for CJC-1295 DAC or CJC-1295 No DAC, demand verifiable documentation across these critical metrics:
• Purity Verification: Require lot-specific High-Performance Liquid Chromatography (RP-HPLC) showing absolute purity ≥99.0%.
• Mass Spectrometry (MS): Electrospray Ionization Mass Spectrometry (ESI-MS) reports validating exact molecular weight matching the theoretical identity.
• Endotoxin Testing: Quantitative LAL assay reports proving bacterial endotoxin levels remain below strict safety limits (<0.01 EU/mg).
• Sourcing & Manufacturing: USA-based synthesis and automated sterile vial filling operating under rigorous quality control standards.
• Traceability & Support: Batch numbers printed directly on every vial matching accessible, online Certificate of Analysis (COA) records.
Sourcing peptides for sensitive cell-culture assays or preclinical research requires avoiding compromised materials. Common red flags in the supply chain include:
• Generic COAs: Vendors supplying static or outdated analytical reports without lot-specific match numbers.
• Unlabeled Mass Specs: Failure to publish full mass spectrum graphs alongside HPLC chromatograms.
• Unverifiable Claims: Overseas suppliers marketing finished products without independent, third-party US laboratory validation.
• Absence of Endotoxin Testing: Omitting bacterial contamination screening, which causes cell culture toxicity or non-specific inflammatory responses in vitro.
High-volume institutions requiring reliable material validation can explore our bulk research peptide ordering program for institution-level supply lines.
GHRH analogs are frequently investigated alongside complementary somatotrophic secretagogues to evaluate synergistic receptor pathways. In addition to CJC-1295 No DAC, key research peptides in this domain include:
• Ipamorelin 5 mg research vials: A selective ghrelin/growth hormone secretagogue receptor (GHSR) agonist studied for pulsatile GH release without elevating cortisol or prolactin.
• Tesamorelin peptide vials: A stabilized GHRH analog heavily researched for lipodystrophy models and hepatic lipid oxidation.
• Sermorelin research overview: The truncated 29-amino-acid amino-terminal segment of endogenous GHRH, widely utilized in fundamental pituitary secretion assays.
PX1 Research is dedicated to providing American laboratories with verified, ultra-pure reference standards. Every order of CJC-1295 No DAC features high-grade lyophilized powder sealed in light-protective glass vials under inert argon atmospheres.
Orders placed before 3:00 PM EST Monday through Friday dispatch same-day directly from our primary distribution hubs in California and Arizona. Fast, tracked domestic shipping ensures your research schedule proceeds without unnecessary delay.
Every batch includes instant public access to third-party HPLC, MS, and endotoxin reports tied directly to your vial's lot number. For technical inquiries or dedicated support, contact our US-based specialist team. Ready to restock your inventory? You can purchasing CJC-1295 No DAC research vials directly online.
cjc 1295 dac reconstitution: what is the recommended procedure?
For CJC 1295 DAC reconstitution, swab the vial stopper with 70% isopropyl alcohol, slowly introduce 1 to 2 mL of bacteriostatic water down the inside glass wall, and gently swirl until dissolved. Never shake the vial.
What is the key structural difference in cjc 1295 no dac?
CJC 1295 No DAC lacks the maleimidopropionic acid Drug Affinity Complex linker. This results in a short, physiological half-life (~30 minutes) compared to the extended multi-day half-life of DAC-bound variants.
How do I calculate volume for cjc no dac reconstitution?
Divide the total milligrams of peptide by the diluent volume added. For instance, adding 2 mL of bacteriostatic water to a 5 mg CJC-1295 No DAC vial yields a concentration of 2.5 mg/mL (250 mcg per 0.1 mL).
Which diluent is best for CJC-1295 reconstitution?
Sterile 0.9% bacteriostatic water containing benzyl alcohol is recommended for multi-dose laboratory handling. It inhibits bacterial growth while preserving peptide integrity at 2°C to 8°C storage conditions.
How long does reconstituted CJC-1295 remain stable under refrigeration?
Reconstituted CJC-1295 remains stable for up to 28 to 30 days when maintained at 2°C to 8°C in sterile bacteriostatic water. Protect the vial from direct sunlight and repeated thermal fluctuation.
What purity level should be verified for CJC-1295 research vials?
High-purity research standards require ≥99.0% purity verified by RP-HPLC, along with mass spectrometry identification and low endotoxin levels (<0.01 EU/mg) to prevent experimental distortion.
Do PX1 Research peptides include lot-specific COAs?
Yes. PX1 Research provides downloadable third-party COAs for every lot, including complete HPLC chromatograms, mass spectrometry reports, and quantitative bacterial endotoxin assays.
How fast does PX1 Research ship CJC-1295 orders?
All orders placed before 3:00 PM EST Monday through Friday ship same-day from warehouse locations in California and Arizona via tracked domestic carriers.
Is CJC-1295 No DAC frequently studied alongside Ipamorelin?
Yes. Preclinical studies often combine CJC-1295 No DAC with Ipamorelin to investigate complementary pituitary GH release pathways without disrupting baseline endocrine rhythms.
Can reconstituted CJC-1295 be refrozen after dissolving?
Refreezing liquid CJC-1295 solutions is not recommended. Repeated freeze-thaw cycles cause structural degradation and peptide aggregation, reducing effective solution potency.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.